Endometriosis Study: 

Prof. Mechsner from Charité in Berlin is conducting a double-blind RCT on Endometriosis and the Oska Pulse Device.  The facility is World renowned for its clinical trials and Prof Mechsner is highly regarded through Europe for this condition. She also sits on the EU and German committees that advise on the treatment for Endometriosis. IRB approval was received and the study started December 2023 with an expected completion in summer 2025 with a publication shortly after.

Oska has been used successfully by customers with this condition and is also used successfully for women who suffer menstrual pain each month. PEMF is not a cure for Endometriosis but works on reducing inflammation and pain and enabling those living with this condition to continue a normal life.

 https://frauenklinik.charite.de/metas/probandensuche/item/probanden_detail/klinische_effekte_einer_stimulation_mit_pulsierenden_elektromagnetischen_feldern_pemf_bei_patient

* These studies are exploring potential additional applications, not yet approved in the US.

* Oska is an FDA cleared class 1 device used to treat pain in the US and a class IIa medical device approved to treat inflammation, improve healing and treat arthritis in Europe, England, Australia and all CE recognizing nations.